CDC Advisers Try To Work Out The Details On Booster Shots

The transcript discusses the consideration of recommending booster shots, following the FDA's approval of a third Pfizer vaccine dose for those over 65 and high-risk adults. The CDC panel is set to evaluate the benefits and risks of booster doses, with some members expressing skepticism and a desire for more evidence before making a recommendation.

What factors are being weighed by the CDC panel in their discussion of booster doses?

What is the significance of the evidence being discussed by the CDC panel?